Back to Search
Start Over
Biomarkers in Type 2 diabetes: improving risk stratification with the PreDx ® Diabetes Risk Score.
- Source :
-
Expert review of molecular diagnostics [Expert Rev Mol Diagn] 2011 Nov; Vol. 11 (8), pp. 775-92. - Publication Year :
- 2011
-
Abstract
- Type 2 diabetes is a chronic, debilitating and often deadly disease that has reached epidemic proportions. The onset of diabetes can be delayed or prevented in high-risk individuals by diet and lifestyle changes and medications, and hence a key element for addressing the diabetes epidemic is to identify those most at risk of developing diabetes so that preventative measures can be effectively focused. The PreDx(®) Diabetes Risk Score is a multimarker tool for assessing a patient's risk of developing diabetes within the next 5 years. Requiring a simple blood draw using standard sample collection and handling procedures, the PreDx Diabetes Risk Score is easily implemented in clinical practice and provides an assessment of diabetes risk that is superior to other measures, including fasting plasma glucose, glycated hemoglobin, measures of insulin resistance and other clinical measures. In this article, we provide an overview of the PreDx Diabetes Risk Score.
- Subjects :
- Adiponectin blood
Blood Glucose analysis
C-Reactive Protein biosynthesis
Diabetes Mellitus, Type 2 blood
Diabetes Mellitus, Type 2 diet therapy
Diabetes Mellitus, Type 2 prevention & control
Female
Ferritins blood
Glycated Hemoglobin biosynthesis
Humans
Insulin blood
Interleukin-2 Receptor alpha Subunit blood
Life Style
Male
Reagent Kits, Diagnostic
Risk
Risk Assessment
Biomarkers blood
Diabetes Mellitus, Type 2 diagnosis
Subjects
Details
- Language :
- English
- ISSN :
- 1744-8352
- Volume :
- 11
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Expert review of molecular diagnostics
- Publication Type :
- Academic Journal
- Accession number :
- 22022939
- Full Text :
- https://doi.org/10.1586/erm.11.63